Sitravatinib (MGCD516) and Nivolumab in Oral cavity cancer Window opportunity study (SNOW)

  • Posted on: 14 August 2018
  • By: admin
Sponsor: 
In-house
NCT#: 
NCT03575598
Eligible Tumour Types: 
Squamous Cell Carcinoma of the Oral Cavity
Recruiting Status: 
Recruiting Soon
Principal Investigator: 
Lillian Siu